Tag Archives: in silico immunogenicity assessment

Update: Screening for Immunogenicity: Immunotherapy Challenges and Predictive Approaches Applied to Therapeutic Proteins 

Update: This event has been cancelled by the organizers. Thank you for your interest. As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in … Continue reading

Posted in Events, Featured | Tagged , , , , , , , , , , , | Leave a comment